Logo image of HZN

Horizon Global Corporation (HZN) Stock Fundamental Analysis

NYSE:HZN - New York Stock Exchange, Inc. - US44052W1045 - Common Stock - Currency: USD

1.76  0 (0%)

After market: 1.7501 -0.01 (-0.56%)

Fundamental Rating

0

Taking everything into account, HZN scores 0 out of 10 in our fundamental rating. HZN was compared to 80 industry peers in the Automobile Components industry. Both the profitability and financial health of HZN have multiple concerns. HZN is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HZN has reported negative net income.
HZN had a negative operating cash flow in the past year.
HZN Yearly Net Income VS EBIT VS OCF VS FCFHZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M -50M -100M -150M -200M

1.2 Ratios

HZN has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HZN Yearly ROA, ROE, ROICHZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 200 400 600

1.3 Margins

In the last couple of years the Operating Margin of HZN has declined.
HZN has a Gross Margin of 10.89%. This is in the lower half of the industry: HZN underperforms 65.12% of its industry peers.
HZN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HZN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.89%
OM growth 3YN/A
OM growth 5Y-16.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.93%
GM growth 5Y-5.9%
HZN Yearly Profit, Operating, Gross MarginsHZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20 -20

More info and screens

0

2. Health

2.1 Basic Checks

HZN does not have a ROIC to compare to the WACC, probably because it is not profitable.
HZN has more shares outstanding than it did 1 year ago.
HZN has a worse debt/assets ratio than last year.
HZN Yearly Shares OutstandingHZN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M 25M
HZN Yearly Total Debt VS Total AssetsHZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M

2.2 Solvency

HZN has an Altman-Z score of 0.51. This is a bad value and indicates that HZN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.51, HZN is not doing good in the industry: 74.42% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACCN/A
WACC8.79%
HZN Yearly LT Debt VS Equity VS FCFHZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 1.12 indicates that HZN should not have too much problems paying its short term obligations.
HZN has a Current ratio of 1.12. This is amonst the worse of the industry: HZN underperforms 81.40% of its industry peers.
A Quick Ratio of 0.45 indicates that HZN may have some problems paying its short term obligations.
HZN has a worse Quick ratio (0.45) than 88.37% of its industry peers.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.45
HZN Yearly Current Assets VS Current LiabilitesHZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

More info and screens

1

3. Growth

3.1 Past

HZN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -303.62%.
Looking at the last year, HZN shows a very negative growth in Revenue. The Revenue has decreased by -14.92% in the last year.
Measured over the past years, HZN shows a small growth in Revenue. The Revenue has been growing by 3.80% on average per year.
EPS 1Y (TTM)-303.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-922.22%
Revenue 1Y (TTM)-14.92%
Revenue growth 3Y3.08%
Revenue growth 5Y3.8%
Sales Q2Q%-24.2%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
HZN Yearly Revenue VS EstimatesHZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M
HZN Yearly EPS VS EstimatesHZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HZN. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HZN Price Earnings VS Forward Price EarningsHZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HZN Per share dataHZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for HZN!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Horizon Global Corporation

NYSE:HZN (2/7/2023, 8:04:00 PM)

After market: 1.7501 -0.01 (-0.56%)

1.76

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)N/A N/A
Earnings (Next)03-08 2023-03-08/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners83.22%
Ins Owner Change0%
Market Cap48.81M
Analysts42.5
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.56
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.41
FCFYN/A
OCF(TTM)-1.77
OCFYN/A
SpS24.35
BVpS-3.91
TBVpS-5.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.89%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5Y-16.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.93%
GM growth 5Y-5.9%
F-Score1
Asset Turnover1.65
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 91.92%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.45
Altman-Z 0.51
F-Score1
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)65.3%
Cap/Depr(5y)71.66%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-303.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-922.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.92%
Revenue growth 3Y3.08%
Revenue growth 5Y3.8%
Sales Q2Q%-24.2%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-310.1%
EBIT growth 3YN/A
EBIT growth 5Y-13.83%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-673.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-333.6%
OCF growth 3YN/A
OCF growth 5YN/A